EP1259537A4 - Genexpressionssystem basierend auf chimären rezeptoren - Google Patents

Genexpressionssystem basierend auf chimären rezeptoren

Info

Publication number
EP1259537A4
EP1259537A4 EP01912956A EP01912956A EP1259537A4 EP 1259537 A4 EP1259537 A4 EP 1259537A4 EP 01912956 A EP01912956 A EP 01912956A EP 01912956 A EP01912956 A EP 01912956A EP 1259537 A4 EP1259537 A4 EP 1259537A4
Authority
EP
European Patent Office
Prior art keywords
gene expression
system based
expression system
chimeric receptors
chimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01912956A
Other languages
English (en)
French (fr)
Other versions
EP1259537A1 (de
Inventor
Fred H Gage
Steven T Suhr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of EP1259537A1 publication Critical patent/EP1259537A1/de
Publication of EP1259537A4 publication Critical patent/EP1259537A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
EP01912956A 2000-02-24 2001-02-23 Genexpressionssystem basierend auf chimären rezeptoren Withdrawn EP1259537A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18459100P 2000-02-24 2000-02-24
US184591P 2000-02-24
PCT/US2001/005750 WO2001062780A1 (en) 2000-02-24 2001-02-23 Gene expression system based on chimeric receptors

Publications (2)

Publication Number Publication Date
EP1259537A1 EP1259537A1 (de) 2002-11-27
EP1259537A4 true EP1259537A4 (de) 2004-05-12

Family

ID=22677535

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01912956A Withdrawn EP1259537A4 (de) 2000-02-24 2001-02-23 Genexpressionssystem basierend auf chimären rezeptoren

Country Status (3)

Country Link
EP (1) EP1259537A4 (de)
AU (1) AU2001241682A1 (de)
WO (1) WO2001062780A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8105825B2 (en) 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
DK1572862T3 (da) * 2001-02-20 2012-11-26 Intrexon Corp Kimære, retinoide x-receptorer og deres anvendelse i et hidtil ukendt ecdysonrecepttorbaseret inducerbart genekspressionssystem
JP4994563B2 (ja) 2001-02-20 2012-08-08 イントレキソン コーポレーション 新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
CA2445796C (en) 2001-02-20 2014-09-16 Rheogene, Inc. Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
PT1456346E (pt) * 2001-02-20 2012-05-02 Intrexon Corp Novo sistema de expressão de genes induzido baseado no recetor de ecdisona / recetor x retinoide invertebrado
CA2459827C (en) 2001-09-26 2013-09-03 Subba Reddy Palli Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
US7304161B2 (en) 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7456315B2 (en) 2003-02-28 2008-11-25 Intrexon Corporation Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7935510B2 (en) 2004-04-30 2011-05-03 Intrexon Corporation Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
AU2014227571B2 (en) 2013-03-15 2017-02-02 Intrexon Corporation Boron-containing diacylhydrazines
TW201625650A (zh) 2014-09-17 2016-07-16 英翠克頌公司 含硼之二醯基肼化合物
US20200362366A1 (en) 2018-01-12 2020-11-19 Basf Se Gene underlying the number of spikelets per spike qtl in wheat on chromosome 7a
AU2019273683A1 (en) 2018-05-25 2020-11-26 Basf Se Plants comprising wheat G-type cytoplasmic male sterility restorer genes and uses thereof
CA3099621A1 (en) 2018-05-25 2019-11-28 Basf Se Plants comprising wheat g-type cytoplasmic male sterility restorer genes and uses thereof
WO2019224359A1 (en) 2018-05-25 2019-11-28 Basf Se Plants comprising wheat g-type cytoplasmic male sterility restorer genes and uses thereof
WO2019234231A1 (en) 2018-06-08 2019-12-12 Basf Se Plants comprising wheat g-type cytoplasmic male sterility restorer genes and uses thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011235A1 (en) * 1991-12-06 1993-06-10 The Salk Institute For Biological Studies Multimeric forms of members of the steroid/thyroid superfamily of receptors
WO1997038117A1 (en) * 1996-04-05 1997-10-16 The Salk Institute For Biological Studies Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
US5830462A (en) * 1993-02-12 1998-11-03 President & Fellows Of Harvard College Regulated transcription of targeted genes and other biological events
WO1999002683A1 (en) * 1997-07-10 1999-01-21 The Salk Institute For Biological Studies Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression
WO1999010508A1 (en) * 1997-08-27 1999-03-04 Ariad Gene Therapeutics, Inc. Chimeric transcriptional activators and compositions and uses related thereto
US5880333A (en) * 1995-03-03 1999-03-09 Novartis Finance Corporation Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
EP0965644A2 (de) * 1998-06-17 1999-12-22 Rohm And Haas Company Liganden zur Beeinflussung der Expression exogener Gene mittels eines Ecdysone-Rezeptor-Komplexes
WO2001036447A2 (en) * 1999-10-20 2001-05-25 The Salk Institute For Biological Studies Hormone receptor functional entities and methods of their use
WO2002066612A2 (en) * 2001-02-20 2002-08-29 Rheogene, Inc. Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5834213A (en) * 1991-05-02 1998-11-10 Baylor College Of Medicine Screening system and assay for identifying compounds that regulate steroid and orphan receptors mediation of DNA transcription
US5728548A (en) * 1995-06-29 1998-03-17 Genetics Institute, Inc. Retinoid receptor-1 (RR1) and DNA encoding RR1

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011235A1 (en) * 1991-12-06 1993-06-10 The Salk Institute For Biological Studies Multimeric forms of members of the steroid/thyroid superfamily of receptors
US5830462A (en) * 1993-02-12 1998-11-03 President & Fellows Of Harvard College Regulated transcription of targeted genes and other biological events
US5880333A (en) * 1995-03-03 1999-03-09 Novartis Finance Corporation Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
WO1997038117A1 (en) * 1996-04-05 1997-10-16 The Salk Institute For Biological Studies Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
WO1999002683A1 (en) * 1997-07-10 1999-01-21 The Salk Institute For Biological Studies Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression
WO1999010508A1 (en) * 1997-08-27 1999-03-04 Ariad Gene Therapeutics, Inc. Chimeric transcriptional activators and compositions and uses related thereto
EP0965644A2 (de) * 1998-06-17 1999-12-22 Rohm And Haas Company Liganden zur Beeinflussung der Expression exogener Gene mittels eines Ecdysone-Rezeptor-Komplexes
WO2001036447A2 (en) * 1999-10-20 2001-05-25 The Salk Institute For Biological Studies Hormone receptor functional entities and methods of their use
WO2002066612A2 (en) * 2001-02-20 2002-08-29 Rheogene, Inc. Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LE DOUARIN B ET AL: "A NEW VERSION OF THE TWO-HYBRID ASSAY FOR DETECTION OF PROTEIN-PROTEIN INTERACTIONS", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 23, no. 5, 11 March 1995 (1995-03-11), pages 876 - 878, XP002012441, ISSN: 0305-1048 *
See also references of WO0162780A1 *

Also Published As

Publication number Publication date
WO2001062780A1 (en) 2001-08-30
EP1259537A1 (de) 2002-11-27
AU2001241682A1 (en) 2001-09-03

Similar Documents

Publication Publication Date Title
ZA200210206B (en) Expression system.
AU2001282531A1 (en) Consumables supply system
EP1259537A4 (de) Genexpressionssystem basierend auf chimären rezeptoren
PL363471A1 (en) An improved heater
EP1189921A4 (de) Synthetische gene zur erhöhten expression
GB0019745D0 (en) Gene expression element
GB0007651D0 (en) Gene sequence
HK1044811A1 (zh) 尤其適用於鋪設木板地板的覆層部件
IL152742A0 (en) Ink supply system
AU6424701A (en) Gasc1 gene
AU2001239731A1 (en) Chimeric neuropeptide y receptors
AU1010401A (en) Printhead for pen
MXPA02008238A (es) Gen humano de la esquizofrenia.
SG89406A1 (en) Carrying system
GB0013289D0 (en) Location system
GB2362383B (en) Gene expression system
GB0000474D0 (en) Receptor
AU1252102A (en) Receptor
AU145391S (en) Interface unit
GB0005856D0 (en) Genetic constructs
IL142392A0 (en) Liquid feed system
IL147004A0 (en) Chimeric oca-b transcription factors
EP1092021A4 (de) Gen des npy-y7 rezeptors
GB9923153D0 (en) Chimeric antibodies
GB0016699D0 (en) Expression system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020923

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/10 B

Ipc: 7C 07K 14/72 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 07K 14/00 A

Ipc: 7C 12N 5/00 B

Ipc: 7C 07K 14/705 B

Ipc: 7C 12N 15/62 B

A4 Supplementary search report drawn up and despatched

Effective date: 20040324

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20040715